{"id":"W4221131077","doi":"10.1016/j.lungcan.2022.03.003","title":"Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"United Therapeutics Corporation","keywords":"Irinotecan; Topotecan; Medicine; Tolerability; Internal medicine; Clinical endpoint; Oncology; Lung cancer; Randomized controlled trial; Chemotherapy; Cancer; Adverse effect; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005338402,0.0004205287,0.001831193,0.0002431283,0.0004122495,0.00001889783,0.0003179315,0.0000670658,0.0006472266],"category_scores_gemma":[0.0001201239,0.000263915,0.0003635218,0.0005936011,0.0003411311,0.00005857126,0.0003550519,0.0002784633,1.022457e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001135267,"about_ca_system_score_gemma":0.001034108,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008114841,"about_ca_topic_score_gemma":0.005460285,"domain_scores_codex":[0.9969347,0.0003406995,0.0008042318,0.0006640487,0.0006637274,0.0005926001],"domain_scores_gemma":[0.9978046,0.0004929677,0.0005186248,0.0007199718,0.0002979702,0.0001658379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6317653,0.02600743,0.1627158,0.01057416,0.01313842,0.0002783583,0.0508065,0.003220404,0.07797129,0.0001112196,0.006663909,0.01674716],"study_design_scores_gemma":[0.8673241,0.01541096,0.008309178,0.0004974885,0.006069363,0.0000273346,0.004236455,0.008716268,0.08326221,0.00002686214,0.005433198,0.0006866227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9732829,0.01373611,0.00006552642,0.001429559,0.0006059198,0.009573987,0.001058702,0.00004444187,0.0002029024],"genre_scores_gemma":[0.9899855,0.001730966,0.00007392935,0.0001737691,0.0002994715,0.004509821,0.00002623579,0.000076164,0.003124186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2355587,"threshold_uncertainty_score":0.9999813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03267758269187104,"score_gpt":0.3941030074496166,"score_spread":0.3614254247577455,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}